The BH3-only protein BID impairs the p38-mediated stress response and promotes hepatocarcinogenesis during chronic liver injury in mice.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Buitrago-Molina, Laura Elisa
Manns, Michael P
MetadataShow full item record
AbstractApoptosis is critical for maintaining tissue homeostasis, and apoptosis evasion is considered as a hallmark of cancer. However, increasing evidence also suggests that proapoptotic molecules can contribute to the development of cancer, including liver cancer. The aim of this study was to further clarify the role of the proapoptotic B-cell lymphoma 2 homology domain 3 (BH3)-only protein BH3 interacting-domain death agonist (BID) for chronic liver injury (CLI) and hepatocarcinogenesis (HCG). Loss of BID significantly delayed tumor development in two mouse models of Fah-mediated and HBsTg-driven HCG, suggesting a tumor-promoting effect of BID. Liver injury as well as basal and mitogen-stimulated hepatocyte proliferation were not modulated by BID. Moreover, there was no in vivo or in vitro evidence that BID was involved in DNA damage response in hepatocytes and hepatoma cells. Our data revealed that CLI was associated with strong activation of oxidative stress (OS) response and that BID impaired full activation of p38 after OS.
CitationThe BH3-only protein BID impairs the p38-mediated stress response and promotes hepatocarcinogenesis during chronic liver injury in mice. 2015, 62 (3):816-28 Hepatology
AffiliationHannover Medical School, Hannover, Germany.
JournalHepatology (Baltimore, Md.)
The following license files are associated with this item:
- Hepatocyte-specific Bid depletion reduces tumor development by suppressing inflammation-related compensatory proliferation.
- Authors: Wree A, Johnson CD, Font-Burgada J, Eguchi A, Povero D, Karin M, Feldstein AE
- Issue date: 2015 Dec
- Bid agonist regulates murine hepatocyte proliferation by controlling endoplasmic reticulum calcium homeostasis.
- Authors: Ni HM, Baty CJ, Li N, Ding WX, Gao W, Li M, Chen X, Ma J, Michalopoulos GK, Yin XM
- Issue date: 2010 Jul
- The strength of the Fas ligand signal determines whether hepatocytes act as type 1 or type 2 cells in murine livers.
- Authors: Schüngel S, Buitrago-Molina LE, Nalapareddy Pd, Lebofsky M, Manns MP, Jaeschke H, Gross A, Vogel A
- Issue date: 2009 Nov
- Activation of the Mitochondrial Apoptotic Pathway Produces Reactive Oxygen Species and Oxidative Damage in Hepatocytes That Contribute to Liver Tumorigenesis.
- Authors: Hikita H, Kodama T, Tanaka S, Saito Y, Nozaki Y, Nakabori T, Shimizu S, Hayashi Y, Li W, Shigekawa M, Sakamori R, Miyagi T, Hiramatsu N, Tatsumi T, Takehara T
- Issue date: 2015 Aug
- Deletion of Bid impedes cell proliferation and hepatic carcinogenesis.
- Authors: Bai L, Ni HM, Chen X, DiFrancesca D, Yin XM
- Issue date: 2005 May